The meropenem group had a greater number of patients with biliary pancreatitis, among whom there was a higher rate of infections 15% than there was among patients with alcoholic pancreatitis 9%. However; the overall distribution was not significantly different between groups p> 0.1.
En el grupo de meropenem existía mayor número de pancreatitis biliares las cuales tienen mayor tasa de infecciones 15% que las pancreatitis alcohólicas 9%; sin embargo, la distribución global no fue significativamente diferente entre ambos grupos p > 0,1.